Unlocking the potential of established products: toward new incentives rewarding innovation in Europe

Background: Many established products (EPs – marketed for eight years or more) are widely used off-label despite little evidence on benefit–risk ratio. This exposes patients to risks related to safety and lack of efficacy, and healthcare providers to liability. Introducing new indications for EPs ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayroles, Gabrielle, Frybourg, Sandrine, Gabriel, Sylvie, Kornfeld, Åsa, Antoñanzas-Villar, Fernando, Espín, Jaime, Jommi, Claudio, Martini, Nello, de Pouvourville, Gérard, Tolley, Keith, Wasem, Jürgen, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508393/
https://www.ncbi.nlm.nih.gov/pubmed/28740616
http://dx.doi.org/10.1080/20016689.2017.1298190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508393/
https://www.ncbi.nlm.nih.gov/pubmed/28740616
http://dx.doi.org/10.1080/20016689.2017.1298190

Ejemplares similares